Building a pancreatic cancer database from real hospital cases
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study creates a large database of real pancreatic cancer cases to help train a computer model. If you had pancreatic cancer treated in this hospital with complete medical records, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated for pancreatic cancer in the hospital
- You have complete medical records (like doctor notes, test results, and surgery reports)
- Your case was discussed by a team of doctors (MDT) or was complex or life-threatening
- Your care was not just a quick emergency or outpatient visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects medical and lab information from adults with pancreatic cancer to help researchers understand care and outcomes. You may be asked for follow-up visits and basic data, and it may be used to improve future treatments.
This study builds a computer model to predict how well pancreatic cancer patients will respond to surgery and what their long-term outcomes might be. Researchers use CT scans, blood tests, and medical records from patients who had pancreatic cancer surgery to teach the model to recognize patterns that help predict outcomes.
This study uses data from patients with pancreatic conditions and healthy people to improve care through computer analysis. It may help researchers develop better tools for diagnosis and treatment.
This study collects information from people diagnosed with pancreatic cancer. It aims to improve care by learning from your medical records.
This is a research registry that collects information from adults with suspected or diagnosed pancreatic cancer. It may help doctors better understand the disease and improve care over time.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.